the-lancet-neurology
The Lancet Neurology (the-lancet-neurology)
Journal positioning
The Lancet Neurology is the leading specialty journal in the Lancet family focused on clinical neurology and neuroscience with clinical relevance, published by Elsevier. It publishes practice-changing neurological trials, major epidemiological studies on neurological disease burden, translational advances directly linked to clinical neurology, and policy analyses for neurological disease control. The editorial culture mirrors the Lancet parent: rigorous trial registration, CONSORT compliance, a global-health and equity lens, and an insistence that findings shift neurological practice or policy at scale. Purely mechanistic neuroscience or animal-model studies without a compelling clinical bridge are out of scope; equally, confirmatory or incremental clinical studies that do not alter existing practice will not meet the bar.
This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on the Lancet/Elsevier site or submission system.
When to trigger
- The author names The Lancet Neurology as the target venue for a neurological clinical trial, disease-burden analysis, or translational neurology study.
- A phase III trial in stroke, multiple sclerosis, Parkinson's disease, epilepsy, dementia, neuro-oncology, or another major neurological disease has results that change standard of care.
- A neurological disease-burden analysis or neuroepidemiology study has global-health policy implications and is ready for high-impact specialty publication.
- The author needs The Lancet Neurology's desk-reject risks and credible alternatives before submitting.